secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2025-07-07T23:59:59+00:00
Accession:  0001193125-25-155830
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inovio prices $25M public offering of common stock and warrants
---------------------------------------------------------------

- Gross proceeds of $25M from 14,285,715 shares and accompanying Series A/B warrants at $1.75/unit.
- Net proceeds expected ~$22.5M after underwriting discounts and expenses; closing on July 7, 2025.
- Underwriters have 30-day option for up to 2,142,857 additional shares and warrants.
- Series A warrants expire 12 months from issuance or 30 days after FDA acceptance of BLA for INO-3107.
- Series B warrants expire 5 years; Piper Sandler sole book-runner, Oppenheimer passive bookrunner.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312525155830/0001193125-25-155830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312525155830/d15686d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-155830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer